Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exicure (XCUR) EBITDA (2016 - 2025)

Exicure's EBITDA history spans 10 years, with the latest figure at -$2.3 million for Q4 2025.

  • For Q4 2025, EBITDA rose 70.27% year-over-year to -$2.3 million; the TTM value through Dec 2025 reached -$4.2 million, up 65.61%, while the annual FY2025 figure was -$4.2 million, 65.39% up from the prior year.
  • EBITDA reached -$2.3 million in Q4 2025 per XCUR's latest filing, up from -$2.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $18.6 million in Q4 2022 to a low of -$23.1 million in Q3 2021.
  • Average EBITDA over 5 years is -$4.8 million, with a median of -$3.9 million recorded in 2023.
  • Peak YoY movement for EBITDA: crashed 2376.59% in 2021, then surged 452.75% in 2025.
  • A 5-year view of EBITDA shows it stood at -$13.4 million in 2021, then soared by 238.26% to $18.6 million in 2022, then tumbled by 108.06% to -$1.5 million in 2023, then tumbled by 406.61% to -$7.6 million in 2024, then surged by 70.27% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for XCUR's EBITDA are -$2.3 million (Q4 2025), -$2.4 million (Q3 2025), and -$2.5 million (Q2 2025).